HOTAIR‐EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma

BACKGROUND: Glioblastoma (GBM) is the most common primary tumor in the brain, and the median survival time for GBM patients is only about 14 months; therefore, there is an urgent need for new and more effective strategies. Since cell cycle disorder is a key factor in tumor progression and immortaliz...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Transl Med
Prif Awduron: Shi, Jin, Lv, Shigang, Wu, Miaojing, Wang, Xianggan, Deng, Yan, Li, Yansheng, Li, Kuanxun, Zhao, Hongyu, Zhu, Xingen, Ye, Minhua
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7240863/
https://ncbi.nlm.nih.gov/pubmed/32508030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ctm2.21
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg